Boltz-2 opens joint structure and binding-affinity prediction
MIT Jameel Clinic and Recursion released MIT-licensed Boltz-2 weights and code for predicting molecular structures together with binding affinity, including an accessible screening workflow for drug discovery.
Why it matters: The release combined two usually separate computational steps and made the implementation inspectable, potentially broadening access to early-stage molecular screening experiments.